Nihon Kagaku Sangyo Co., Ltd.
Notice of Revision to Earnings Guidance
Revised consolidated earnings guidance for the fiscal year ending March 2027. Net sales increased by 1,190 million yen from the previous forecast, operating income increased by 490 million yen, ordinary income increased by 700 million yen, net income attributable to owners of parent increased by 530 million yen, and diluted net income per share was revised upward from 64.23 yen to 91.30 yen. Strong performance driven by AI-related demand in the pharmaceutical business and a surge in non-ferrous metal prices, prompting an upward revision to full-year outlook. No change to dividend forecast.
Key Figures
- Net Sales: 29,830 million yen (previous 28,640 million yen)
- Operating Income: 1,800 million yen (previous 1,310 million yen)
- Net Income Attributable to Owners of Parent: 1,780 million yen (previous 1,250 million yen)
AI要約
Overview of Revision to Earnings Guidance
Nihon Kagaku Sangyo Co., Ltd. has revised upward its consolidated earnings guidance for the full fiscal year ending March 2027. Net sales are expected to increase by approximately 1,190 million yen, operating income by approximately 490 million yen, ordinary income by approximately 700 million yen, and net income attributable to owners of parent by approximately 530 million yen, with net income per share projected to rise substantially to 91.30 yen.
Reasons for Revision and Outlook
The revision is mainly driven by increased AI-related demand in the pharmaceutical business and a surge in non-ferrous metal prices, with strong expected demand particularly for products for the electronics industry, leading to a projection above the previous full-year forecast. Contract manufacturing of battery cathode materials was completed in August, and demand in the pharmaceutical and building materials segments is also assumed to remain strong, which is expected to support continued growth. There is no revision to the dividend forecast.
Nihon Kagaku Sangyo Co., Ltd.
Company overview · Stock price · Financial data · All IR
